{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:40:23Z","timestamp":1795038023364,"version":"4.10.2"},"reference-count":104,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Accurate measurements of the platelet count are necessary to diagnose thrombocytosis or thrombocytopenia correctly, gauge the severity of clinical risk and identify the most appropriate therapeutic intervention. Despite increased diagnostic accuracy with electronic counters, counting is still unsatisfactory in rare situations. Conditions causing spurious thrombocytopenia include the following. (i) Pre-analytical errors, such as difficult venipuncture, over-\/under-filling of blood collection tubes, insufficient mixing of blood with the anticoagulant (EDTA), which may cause fibrin formation. (ii) EDTA-induced, temperature- and time-dependent, antibody-mediated in vitro platelet agglutination, with consequent reduction in the number of single platelets in the sample; this condition, referred to as pseudothrombocytopenia, is benign and does not need follow-up or medical interventions; the use of alternative in vitro anticoagulants does not prevent formation of agglutinates in all samples; accurate platelet counts could be obtained by testing EDTA-samples immediately after blood collection. (iii) EDTA-induced in vitro platelet adherence to leukocytes (platelet satellitism), caused by bridging IgG antibodies binding to GPIIb-IIIa on platelets and the Fc receptor-III on leukocytes; occasionally, leukocytes may phagocytose platelets and\/or form platelet\/leukocyte clumps. (iv) The presence of large\/giant platelets (commonly from patients with congenital or acquired thrombocytopenia) that are not recognized as such by electronic counters, which distinguish platelets from other cells based on their smaller size. (v) Type 2B von Willebrand disease: blood from patients with this disorder may display large\/giant platelets and platelet agglutinates. All the above conditions are easily identifiable by microscopic examination of anticoagulated peripheral blood smears, which is an indispensable diagnostic procedure in hematology.<\/jats:p>","DOI":"10.3324\/haematol.2024.286234","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T05:41:09Z","timestamp":1743054069000},"page":"1677-1692","source":"Crossref","is-referenced-by-count":9,"title":["Pseudothrombocytopenia and other conditions associated with spuriously low platelet counts"],"prefix":"10.3324","volume":"110","author":[{"given":"Marco","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"76882","doi-asserted-by":"crossref","unstructured":"Chen Y, Hu Y, Hu H. Advances and challenges in platelet counting: evolving from traditional microscopy to modern flow cytometry. J Lab Med. 2025; 49(1):2-13.","DOI":"10.1515\/labmed-2024-0135"},{"key":"76883","doi-asserted-by":"crossref","unstructured":"Baccini V, Genevi\u00e8ve F, Jacqmin H. Platelet counting: ugly traps and good advice. Proposals from the French-speaking Cellular Hematology Group (GFHC). J Clin Med. 2020; 9(3):808.","DOI":"10.3390\/jcm9030808"},{"key":"76884","doi-asserted-by":"crossref","unstructured":"Balduini CL, Noris P. Platelet count and aging. Haematologica. 2014; 99(6):953-955.","DOI":"10.3324\/haematol.2014.106260"},{"key":"76885","doi-asserted-by":"crossref","unstructured":"Biino G, Santimone I, Minelli C. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects\u2019 data. PLoS One. 2013; 8(1):e54289.","DOI":"10.1371\/journal.pone.0054289"},{"key":"76886","doi-asserted-by":"crossref","unstructured":"Troussard X, Vol S, Cornet E. Full blood count normal reference values for adults in France. J Clin Pathol. 2014; 67(4):341-344.","DOI":"10.1136\/jclinpath-2013-201687"},{"key":"76887","doi-asserted-by":"crossref","unstructured":"De la Salle B. Pre- and postanalytical errors in haematology. Int J Lab Hematol. 2019; 41(Suppl 1):170-176.","DOI":"10.1111\/ijlh.13007"},{"key":"76888","doi-asserted-by":"crossref","unstructured":"Sousa S, Magalh\u00e3es C, Teixeira C, Eremina YO. Fibrin strands in peripheral blood smear: the COVID 19 era. Clin Chem Lab Med. 2022; 60(8):e184-e186.","DOI":"10.1515\/cclm-2022-0199"},{"key":"76889","doi-asserted-by":"crossref","unstructured":"Gowland E, Kay HE, Spillman JC, Williamson JR. Agglutination of platelets by a serum factor in the presence of EDTA. J Clin Pathol. 1969; 22(4):460-464.","DOI":"10.1136\/jcp.22.4.460"},{"key":"76890","doi-asserted-by":"crossref","unstructured":"Pegels JG, Bruynes EC, Engelfriet CP, von dem Borne AE. Pseudothrombocytopenia: an immunologic study on platelet antibodies dependent on ethylene diamine tetra-acetate. Blood. 1982; 59(1):157-161.","DOI":"10.1182\/blood.V59.1.157.bloodjournal591157"},{"key":"76891","doi-asserted-by":"crossref","unstructured":"Bizzaro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol. 1995; 50(2):103-109.","DOI":"10.1002\/ajh.2830500206"},{"key":"76892","doi-asserted-by":"crossref","unstructured":"Nagler M, Keller P, Siegrist D, Alberio L. A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon. BMC Clin Pathol. 2014; 14:19.","DOI":"10.1186\/1472-6890-14-19"},{"key":"76893","doi-asserted-by":"crossref","unstructured":"Pujol-Moix N, Mu\u00f1iz-D\u00edaz E, Espa\u00f1ol I. Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases. Ann Hematol. 2023; 102(6):1363-1374.","DOI":"10.1007\/s00277-023-05192-8"},{"key":"76894","doi-asserted-by":"crossref","unstructured":"Froom P, Barak M. Prevalence and course of pseudothrombocytopenia in outpatients. Clin Chem Lab Med. 2011; 49(1):111-114.","DOI":"10.1515\/CCLM.2011.013"},{"key":"76895","doi-asserted-by":"crossref","unstructured":"Schuff-Werner P, Mansour J, Gropp A. Pseudothrombocytopenia (PTCP). A challenge in the daily laboratory routine?. J Lab Med. 2020; 44(5):295-304.","DOI":"10.1515\/labmed-2020-0099"},{"key":"76896","doi-asserted-by":"crossref","unstructured":"Dahlqvist SR, Nilsson TK, Norberg B. Thrombocytosis in active rheumatoid arthritis. Relation to other parameters of inflammatory activity and confounding effect of automated cell counting. Clin Rheumatol. 1988; 7(3):335-341.","DOI":"10.1007\/BF02239189"},{"key":"76897","doi-asserted-by":"crossref","unstructured":"Cohen AM, Cycowitz Z, Mittelman M. The incidence of pseudothrombocytopenia in automatic blood analyzers. Haematologia (Budap). 2000; 30(2):117-121.","DOI":"10.1163\/15685590051130137"},{"key":"76898","doi-asserted-by":"crossref","unstructured":"Lardinois B, Favresse J, Chatelain B. Pseudothrombocytopenia-a review on causes, occurrence and clinical implications. J Clin Med. 2021; 10(4):594.","DOI":"10.3390\/jcm10040594"},{"key":"76899","doi-asserted-by":"crossref","unstructured":"Payne BA, Pierre RV. Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences. Mayo Clin Proc. 1984; 59(2):123-125.","DOI":"10.1016\/S0025-6196(12)60247-X"},{"key":"76900","doi-asserted-by":"crossref","unstructured":"Berkman N, Michaeli Y, Or R, Eldor A. EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol. 1991; 36(3):195-201.","DOI":"10.1002\/ajh.2830360307"},{"key":"76901","doi-asserted-by":"crossref","unstructured":"Bartels PC, Schoorl M, Lombarts AJ. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia. Scand J Clin Lab Invest. 1997; 57(7):629-636.","DOI":"10.3109\/00365519709055287"},{"key":"76902","doi-asserted-by":"crossref","unstructured":"Lin J, Luo Y, Yao S. Discovery and correction of spurious low platelet counts due to EDTA-dependent pseudothrombocytopenia. J Clin Lab Anal. 2015; 29(5):419-426.","DOI":"10.1002\/jcla.21818"},{"key":"76903","doi-asserted-by":"crossref","unstructured":"Savage RA. Pseudoleukocytosis due to EDTA-induced platelet clumping. Am J Clin Pathol. 1984; 81(3):317-322.","DOI":"10.1093\/ajcp\/81.3.317"},{"key":"76904","doi-asserted-by":"crossref","unstructured":"Garcia Suarez J, Calero MA, Ricard MP. EDTA-dependent pseudothrombocytopenia in ambulatory patients: clinical characteristics and role of new automated cell-counting in its detection. Am J Hematol. 1992; 39(2):146-148.","DOI":"10.1002\/ajh.2830390215"},{"key":"76905","doi-asserted-by":"crossref","unstructured":"Sakurai S, Shiojima I, Tanigawa T, Nakahara K. Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia. Br J Haematol. 1997; 99(4):817-823.","DOI":"10.1046\/j.1365-2141.1997.4773280.x"},{"key":"76906","doi-asserted-by":"crossref","unstructured":"Silvestri F, Virgolini L, Savignano C, Zaja F, Velisig M, Baccarani M. Incidence and diagnosis of EDTA-dependent pseudothrombocytopenia in a consecutive outpatient population referred for isolated thrombocytopenia. Vox Sang. 1995; 68(1):35-39.","DOI":"10.1111\/j.1423-0410.1995.tb02542.x"},{"key":"76907","doi-asserted-by":"crossref","unstructured":"van Vliet HH, Kappers-Klunne MC, Abels J. Pseudothrombocytopenia: a cold autoantibody against platelet glycoprotein GP IIb. Br J Haematol. 1986; 62(3):501-511.","DOI":"10.1111\/j.1365-2141.1986.tb02962.x"},{"key":"76908","doi-asserted-by":"crossref","unstructured":"Mu\u00f1iz-Diaz E, Madoz P, Pujol-Moix N. Characterization of antibodies directed against platelet cryptantigens detected during the immunological study of 356 consecutive patients with presumed autoimmune thrombocytopenia (AITP). Transfus Med. 1995; 5(3):185-191.","DOI":"10.1111\/j.1365-3148.1995.tb00226.x"},{"key":"76909","doi-asserted-by":"crossref","unstructured":"Watkins SP, Shulman NR. Platelet cold agglutinins. Blood. 1970; 36(2):153-158.","DOI":"10.1182\/blood.V36.2.153.153"},{"key":"76910","doi-asserted-by":"crossref","unstructured":"Scavone M, Bossi E, Podda GM, Cattaneo M. MgSO4 anticoagulant prevents pseudothrombocytopenia by preserving the integrity of the platelet GPIIb-IIIa complex. Br J Haematol. 2021; 192(6):e144-e148.","DOI":"10.1111\/bjh.17298"},{"key":"76911","doi-asserted-by":"crossref","unstructured":"Fiorin F, Steffan A, Pradella P. IgG platelet antibodies in EDTA-dependent pseudothrombocytopenia bind to platelet membrane glycoprotein IIb. Am J Clin Pathol. 1998; 110(2):178-183.","DOI":"10.1093\/ajcp\/110.2.178"},{"key":"76912","doi-asserted-by":"crossref","unstructured":"De Caterina M, Fratellanza G, Grimaldi E. Evidence of a cold immunoglobulin M autoantibody against 78-kD platelet glycoprotein in a case of EDTA-dependent pseudothrombocytopenia. Am J Clin Pathol. 1993; 99(2):163-167.","DOI":"10.1093\/ajcp\/99.2.163"},{"key":"76913","doi-asserted-by":"crossref","unstructured":"Asma A, Anissa S, Touhami K. Aggregation kinetic and temperature optimum of an EDTA-dependent pseudothrombocytopenia. Clin Chem Lab Med. 2020; 59(1):e31-e33.","DOI":"10.1515\/cclm-2020-0128"},{"key":"76914","doi-asserted-by":"crossref","unstructured":"Ghali C, Scavone M, Clerici B. Time-dependent in vitro variations of platelet count in samples from subjects with EDTA-induced pseudothrombocytopenia: a comparative analysis across different anticoagulants. Br J Haematol. 2024; 204(5):2125-2128.","DOI":"10.1111\/bjh.19406"},{"key":"76915","doi-asserted-by":"crossref","unstructured":"Gola\u0144ski J, Pietrucha T, Baj Z. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res. 1996; 83(3):199-216.","DOI":"10.1016\/0049-3848(96)00129-6"},{"key":"76916","doi-asserted-by":"crossref","unstructured":"Lippi G, Plebani M. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med. 2012; 50(8):1281-1285.","DOI":"10.1515\/cclm-2012-0081"},{"key":"76917","doi-asserted-by":"crossref","unstructured":"Gogstad GO, Hagen I, Krutnes MB, Solum NO. Dissociation of the glycoprotein IIb-IIIa complex in isolated human platelet membranes. Dependence of pH divalent cations. Biochim Biophys Acta. 1982; 689(1):21-30.","DOI":"10.1016\/0005-2736(82)90184-5"},{"key":"76918","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez Guiu IM, Mart\u00ednez-Martinez I. An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets. Thromb Haemost. 2015; 114(2):313-324.","DOI":"10.1160\/TH14-11-0945"},{"key":"76919","doi-asserted-by":"crossref","unstructured":"Podda G, Femia EA, Pugliano M, Cattaneo M. Congenital defects of platelet function. Platelets. 2012; 23(7):552-563.","DOI":"10.3109\/09537104.2012.724737"},{"key":"76920","doi-asserted-by":"crossref","unstructured":"Agarwal S. Pseudo-grey platelet syndrome: a rare artifact. Indian J Hematol Blood Transfus. 2013; 29(1):52-54.","DOI":"10.1007\/s12288-011-0129-4"},{"key":"76921","doi-asserted-by":"crossref","unstructured":"Pancione Y, Fumi M, Sale S, Rocco V, Bain BJ. Gray platelets - artifact or real?. Am J Hematol. 2016; 91(5):538.","DOI":"10.1002\/ajh.24322"},{"key":"76922","doi-asserted-by":"crossref","unstructured":"Cockbill SR, Burmester HB, Heptinstall S. Pseudo grey platelet syndrome\u2014grey platelets due to degranulation in blood collected into EDTA. Eur J Haematol. 1988; 41(4):326-333.","DOI":"10.1111\/j.1600-0609.1988.tb00205.x"},{"key":"76923","doi-asserted-by":"crossref","unstructured":"Amoruso M, Alberio L, Nagy M. EDTA-related degranulation mimicking storage pool disease. Am J Hematol. 2018; 93(9):1192-1193.","DOI":"10.1002\/ajh.25067"},{"key":"76924","doi-asserted-by":"crossref","unstructured":"Shimizu M, Yamamoto M, Miyachi H. Simple, rapid, and automated method for detection of hyperaggregability of platelets using a hematology analyzer. Am J Hematol. 2003; 72(4):282-283.","DOI":"10.1002\/ajh.10292"},{"key":"76925","doi-asserted-by":"crossref","unstructured":"Cunningham VL, Brandt JT. Spurious thrombocytopenia due to EDTA-independent cold-reactive agglutinins. Am J Clin Pathol. 1992; 97(3):359-362.","DOI":"10.1093\/ajcp\/97.3.359"},{"key":"76926","doi-asserted-by":"crossref","unstructured":"Lombarts AJ, Zijlstra JJ, Peters RH. Accurate platelet counting in an insidious case of pseudothrombocytopenia. Clin Chem Lab Med. 1999; 37(11-12):1063-1066.","DOI":"10.1515\/CCLM.1999.155"},{"key":"76927","doi-asserted-by":"crossref","unstructured":"Sandhaus LM, Osei ES, Agrawal NN. Platelet counting by the Coulter LH 750, Sysmex XE. 2100, and Advia 120: a comparative analysis using the RBC\/platelet ratio reference method. Am J Clin Pathol. 2002; 118(2):235-241.","DOI":"10.1309\/MK3G-MC3V-P06R-PNV2"},{"key":"76928","doi-asserted-by":"crossref","unstructured":"Solanki DL, Blackburn BC. Spurious leukocytosis and thrombocytopenia. A dual phenomenon caused by clumping of platelets in vitro. JAMA. 1983; 250(18):2514-2515.","DOI":"10.1001\/jama.1983.03340180068032"},{"key":"76929","doi-asserted-by":"crossref","unstructured":"Woo S, Kim B, Heo NH. Definition of significant platelet clumping: should we review all samples with a platelet clumping flag from automated hematology analyzer?. Int J Lab Hematol. 2025; 47(1):79-86.","DOI":"10.1111\/ijlh.14387"},{"key":"76930","unstructured":"Adewoyin AS, Nwogoh B. Peripheral blood film - a review. Ann Ib Postgrad Med. 2014; 12(2):71-79."},{"key":"76931","doi-asserted-by":"crossref","unstructured":"Mannu\u00df S, Schuff-Werner P, Drei\u00dfiger K, Burstein C. Inhibition of agonist-induced platelet aggregation by magnesium sulfate warrants its use as an alternative in vitro anticoagulant in pseudothrombocytopenia. Platelets. 2020; 31(5):680-684.","DOI":"10.1080\/09537104.2019.1663804"},{"key":"76932","doi-asserted-by":"crossref","unstructured":"Tan GC, Stalling M, Dennis G. Pseudothrombocytopenia due to platelet clumping: a case report and brief review of the literature. Case Rep Hematol. 2016; 2016:3036476.","DOI":"10.1155\/2016\/3036476"},{"key":"76933","doi-asserted-by":"crossref","unstructured":"Zhou X, Wu X, Deng W. Amikacin can be added to blood to reduce the fall in platelet count. Am J Clin Pathol. 2011; 136(4):646-652.","DOI":"10.1309\/AJCPMON79QKQKRBT"},{"key":"76934","doi-asserted-by":"crossref","unstructured":"Zhong L, Chadha J, Ameri A. A curious case of pseudothrombocytopenia due to in vitro agglutination. Case Rep Hematol. 2020; 2020:6236350.","DOI":"10.1155\/2020\/6236350"},{"key":"76935","doi-asserted-by":"crossref","unstructured":"Farkas JC, Brossel C, Boyer JM. Cold-reactive platelet agglutinins. Thromb Haemost. 1993; 70(5):879-880.","DOI":"10.1055\/s-0038-1649690"},{"key":"76936","unstructured":"Lippi U, Schinella M, Nicoli M. EDTA-induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated complete blood count. Haematologica. 1990; 75(1):38-41."},{"key":"76937","doi-asserted-by":"crossref","unstructured":"Bokaei PB, Grabovsky D, Shehata N, Wang C. Impact of amikacin on pseudothrombocytopenia. Acta Haematol. 2017; 137(1):27-29.","DOI":"10.1159\/000452266"},{"key":"76938","doi-asserted-by":"crossref","unstructured":"Podda GM, Pugliano M, Casazza G. Measurement of platelet count with different anticoagulants in thrombocytopenic patients and healthy subjects: accuracy and stability over time. Haematologica. 2019; 104(12):e570-e572.","DOI":"10.3324\/haematol.2019.222265"},{"key":"76939","doi-asserted-by":"crossref","unstructured":"Ohashi-Fukuda N, Inokuchi R, Sato H. Poorer prognosis with ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia: a single-center case-control study. Medicine (Baltimore). 2015; 94(15):e674.","DOI":"10.1097\/MD.0000000000000674"},{"key":"76940","doi-asserted-by":"crossref","unstructured":"Norberg B, Nilsson TK. Platelet clumping in Ph-negative myeloproliferative syndromes. Acta Med Scand. 1987; 222(5):459-464.","DOI":"10.1111\/j.0954-6820.1987.tb10965.x"},{"key":"76941","unstructured":"Solanki DL, Blackburn BC. Spurious thrombocytopenia during pregnancy. Obstet Gynecol. 1985; 65:14."},{"key":"76942","unstructured":"Chiurazzi F, Villa MR, Rotoli B. Transplacental transmission of EDTA-dependent pseudothrombocytopenia. Haematologica. 1999; 84(7):664."},{"key":"76943","doi-asserted-by":"crossref","unstructured":"Sweeney JD, Holme S, Heaton WA. Pseudothrombocytopenia in plateletpheresis donors. Transfusion. 1995; 35(1):46-49.","DOI":"10.1046\/j.1537-2995.1995.35195090660.x"},{"key":"76944","doi-asserted-by":"crossref","unstructured":"Podda GM, Pugliano M, Femia EA. The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories. Am J Hematol. 2012; 87(7):727-728.","DOI":"10.1002\/ajh.23216"},{"key":"76945","doi-asserted-by":"crossref","unstructured":"Bizzaro N, Brandalise M. EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies. Am J Clin Pathol. 1995; 103(1):103-107.","DOI":"10.1093\/ajcp\/103.1.103"},{"key":"76946","doi-asserted-by":"crossref","unstructured":"Salama A. Autoimmune thrombocytopenia complicated by EDTA- and\/or citrate-dependent pseudothrombocytopenia. Transfus Med Hemother. 2015; 42(5):345-348.","DOI":"10.1159\/000437220"},{"key":"76947","unstructured":"Pujol-Moix N, Espa\u00f1ol I, Soler A, Mu\u00f1iz-Diaz E. Immune thrombocytopenia with associated pseudothrombocytopenia. Am J Leuk Res. 2024; 7(1):1034."},{"key":"76948","doi-asserted-by":"crossref","unstructured":"Sane DC, Damaraju LV, Topol EJ. Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy. J Am Coll Cardiol. 2000; 36(1):75-83.","DOI":"10.1016\/S0735-1097(00)00688-4"},{"key":"76949","doi-asserted-by":"crossref","unstructured":"Schell DA, Ganti AK, Levitt R, Potti A. Thrombocytopenia associated with c7E3 Fab (abciximab). Ann Hematol. 2002; 81(2):76-79.","DOI":"10.1007\/s00277-001-0414-7"},{"key":"76950","doi-asserted-by":"crossref","unstructured":"Huxtable LM, Tafreshi MJ, Rakkar AN. Frequency and management of thrombocytopenia with the glycoprotein IIb\/IIIa receptor antagonists. Am J Cardiol. 2006; 97(3):426-429.","DOI":"10.1016\/j.amjcard.2005.08.066"},{"key":"76951","doi-asserted-by":"crossref","unstructured":"Zeigler Z. In vitro granulocyte-platelet rosette formation mediated by an IgG immunoglobulin. Haemostasis. 1974; 3(5-6):282-287.","DOI":"10.1159\/000214066"},{"key":"76952","doi-asserted-by":"crossref","unstructured":"Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on haematology analysers: a review. Part I: platelets. Int J Lab Hematol. 2007; 29(1):4-20.","DOI":"10.1111\/j.1365-2257.2006.00870.x"},{"key":"76953","doi-asserted-by":"crossref","unstructured":"Sousa SM, Sousa TM, Silva CF, Mendes CC. Pseudothrombocytopenia: a case of platelet satellitism and phagocytosis by neutrophils. Platelets. 2020; 31(4):541-543.","DOI":"10.1080\/09537104.2019.1664733"},{"key":"76954","doi-asserted-by":"crossref","unstructured":"Lopez-Molina M, Sorigue M, Martinez-Iribarren A. Platelet satellitism around lymphocytes: case report and literature review. Int J Lab Hematol. 2019; 41(4):e81-e83.","DOI":"10.1111\/ijlh.12972"},{"key":"76955","doi-asserted-by":"crossref","unstructured":"Cohen AM, Lewinski UH, Klein B, Djaldetti M. Satellitism of platelets to monocytes. Acta Haematol. 1980; 64(2):61-64.","DOI":"10.1159\/000207212"},{"key":"76956","doi-asserted-by":"crossref","unstructured":"Liso V, Bonomo L. Platelet satellitism to basophils in a patient with chronic myelocytic leukaemia. Blut. 1982; 45(5):347-350.","DOI":"10.1007\/BF00319529"},{"key":"76957","doi-asserted-by":"crossref","unstructured":"Lazo-Langner A, Piedras J, Romero-Lagarza P. Platelet satellitism, spurious neutropenia, and cutaneous vasculitis: casual or causal association?. Am J Hematol. 2002; 70(3):246-249.","DOI":"10.1002\/ajh.10141"},{"key":"76958","doi-asserted-by":"crossref","unstructured":"Bizzaro N, Goldschmeding R, von dem Borne AE. Platelet satellitism is Fc gamma RIII (CD16) receptor-mediated. Am J Clin Pathol. 1995; 103(6):740-744.","DOI":"10.1093\/ajcp\/103.6.740"},{"key":"76959","doi-asserted-by":"crossref","unstructured":"Christopoulos C, Mattock C. Platelet satellitism and alpha granule proteins. J Clin Pathol. 1991; 44(9):788-789.","DOI":"10.1136\/jcp.44.9.788"},{"key":"76960","doi-asserted-by":"crossref","unstructured":"Criswell KA, Breider MA, Bleavins MR. EDTA-dependent platelet phagocytosis. A cytochemical, ultrastructural, and functional characterization. Am J Clin Pathol. 2001; 115(3):376-384.","DOI":"10.1309\/MG6T-YQJQ-7C74-RE1V"},{"key":"76961","doi-asserted-by":"crossref","unstructured":"Moraglio D, Banfi G, Arnelli A. Association of pseudothrombocytopenia and pseudoleukopenia: evidence for different pathogenic mechanisms. Scand J Clin Lab Invest. 1994; 54(4):257-265.","DOI":"10.3109\/00365519409087520"},{"key":"76962","doi-asserted-by":"crossref","unstructured":"Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol. 1999; 6(5):342-348.","DOI":"10.1097\/00062752-199909000-00012"},{"key":"76963","doi-asserted-by":"crossref","unstructured":"Balduini CL, Pecci A. Inherited thrombocytopenias. Haematologica. 2020; 105(Supplement 1):237-247.","DOI":"10.3324\/haematol.2019.244939"},{"key":"76964","doi-asserted-by":"crossref","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019; 381(10):945-955.","DOI":"10.1056\/NEJMcp1810479"},{"key":"76965","doi-asserted-by":"crossref","unstructured":"Handtke S, Thiele T. Large and small platelets-(when) do they differ?. J Thromb Haemost. 2020; 18(6):1256-1267.","DOI":"10.1111\/jth.14788"},{"key":"76966","doi-asserted-by":"crossref","unstructured":"Jesudas R, Takemoto CM. Where have all the platelets gone? HIT, DIC, or something else?. Hematology Am Soc Hematol Educ Program. 2023; 2023(1):43-50.","DOI":"10.1182\/hematology.2023000465"},{"key":"76967","doi-asserted-by":"crossref","unstructured":"Tong M, Seth P, Penington DG. Proplatelets and stress platelets. Blood. 1987; 69(2):522-528.","DOI":"10.1182\/blood.V69.2.522.bloodjournal692522"},{"key":"76968","doi-asserted-by":"crossref","unstructured":"Markewitz RDH, Falk KK. Platelet satellitism in immune thrombocytopenic purpura. Blood. 2022; 140(19):2091.","DOI":"10.1182\/blood.2022017491"},{"key":"76969","doi-asserted-by":"crossref","unstructured":"Noris P, Biino G, Pecci A. Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. Blood. 2014; 124(6):e4-e10.","DOI":"10.1182\/blood-2014-03-564328"},{"key":"76970","doi-asserted-by":"crossref","unstructured":"Rees DC, Iolascon A, Carella M. Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis\/ macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol. 2005; 130(2):297-309.","DOI":"10.1111\/j.1365-2141.2005.05599.x"},{"key":"76971","doi-asserted-by":"crossref","unstructured":"Wang L, Huang J, Li X. Marked underestimation of platelet count and a characteristic platelet histogram as clues to MYH9-related disorders. Clin Lab. 2024; 70(3):610-613.","DOI":"10.7754\/Clin.Lab.2023.230918"},{"key":"76972","doi-asserted-by":"crossref","unstructured":"Noris P, Zaninetti C. Counting and measurement of platelet dimensions. 2017;571-588.","DOI":"10.1007\/978-3-319-47462-5_39"},{"key":"76973","doi-asserted-by":"crossref","unstructured":"Sadler JE, Budde U, Eikenboom JC. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor. J Thromb Haemost. 2006; 4(10):2103-2114.","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"76974","doi-asserted-by":"crossref","unstructured":"James PD, Connell NT, Ameer B. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021; 5(1):280-300.","DOI":"10.1182\/bloodadvances.2020003265"},{"key":"76975","doi-asserted-by":"crossref","unstructured":"Othman M, Favaloro EJ. 2B von Willebrand disease diagnosis: considerations reflecting on 2021 multisociety guidelines. Res Pract Thromb Haemost. 2021; 5(8):e12635.","DOI":"10.1002\/rth2.12635"},{"key":"76976","doi-asserted-by":"crossref","unstructured":"Saba HI, Saba SR, Dent J. Type IIB Tampa: a variant of von Willebrand disease with chronic thrombocytopenia, circulating platelet aggregates, and spontaneous platelet aggregation. Blood. 1985; 66(2):282-286.","DOI":"10.1182\/blood.V66.2.282.bloodjournal662282"},{"key":"76977","doi-asserted-by":"crossref","unstructured":"Lu X, Yu D, Dai W. Misdiagnosis of type 2B von Willebrand disease as immune thrombocytopenia in a thrombocytopenic patient. Clin Chem Lab Med. 2024; 62(9):e212-e214.","DOI":"10.1515\/cclm-2023-0891"},{"key":"76978","doi-asserted-by":"crossref","unstructured":"Loffredo G, Baronciani L, Noris P. Von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets. Platelets. 2006; 17(3):149-152.","DOI":"10.1080\/09537100500441150"},{"key":"76979","doi-asserted-by":"crossref","unstructured":"Kumar R, Creary S, Varga EA, Kahwash SB. Thrombocytopenia pitfalls: misdiagnosing type 2B von Willebrand disease as ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia. J Pediatr. 2016; 175:238-238.e1.","DOI":"10.1016\/j.jpeds.2016.04.077"},{"key":"76980","doi-asserted-by":"crossref","unstructured":"Hatta K, Kunishima S, Suganuma H. A family having type 2B von Willebrand disease with a novel VWF p.R1308S mutation: detection of characteristic platelet aggregates on peripheral blood smears as the key aspect of diagnosis. Thromb Res. 2015; 136(4):813-817.","DOI":"10.1016\/j.thromres.2015.08.004"},{"key":"76981","doi-asserted-by":"crossref","unstructured":"Pareti FI, Federici AB, Cattaneo M, Mannucci PM. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb\/IIIa. Br J Haematol. 1990; 75(1):86-91.","DOI":"10.1111\/j.1365-2141.1990.00086.x"},{"key":"76982","doi-asserted-by":"crossref","unstructured":"van Kwawegen CB, Atiq F, Endenburg D. Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study. J Thromb Haemost. 2024; 22(12):3460-3472.","DOI":"10.1016\/j.jtha.2024.08.028"},{"key":"76983","doi-asserted-by":"crossref","unstructured":"Miljic P, Noureldin A, Lavin M. Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians\u2019 survey-communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023; 21(1):154-163.","DOI":"10.1016\/j.jtha.2022.10.019"},{"key":"76984","doi-asserted-by":"crossref","unstructured":"Holmberg L, Nilsson IM, Borge L. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand\u2019s disease. N Engl J Med. 1983; 309(14):816-821.","DOI":"10.1056\/NEJM198310063091402"},{"key":"76985","doi-asserted-by":"crossref","unstructured":"Altomare I, Cetin K, Wetten S, Wasser JS. Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clin Epidemiol. 2016; 8:231-239.","DOI":"10.2147\/CLEP.S105888"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12002\/78259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12002\/78606","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12002\/78259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:08:27Z","timestamp":1794046107000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":104,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286234","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}